US Drug Recall Register
Class III · Low risk Terminated Initiated May 17, 2016 (10 years ago)

CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.

What was recalled

CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15, 1 FL. OZ.LIQ./30 ml bottle within a carton, Clinique Labs., Dist. New York, N.Y., 10022; New York, London W1K 3BQ; Paris, UPC No. 20714-48240-4, Shade 05 (D-G)

Recalling firm
Clinique International
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1477-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Paris recalls

See all
Class II · Moderate risk Terminated

Desmopressin Acetate Tablets

Reason GMP Deviations: Product bottle may be absent of desiccant.

Teva Pharmaceuticals USA NDC 0591-2465-01 D-0831-2020
Class II · Moderate risk Terminated

Desmopressin Acetate Tablets

Reason GMP Deviations: Product bottle may be absent of desiccant.

Teva Pharmaceuticals USA NDC 0591-2464-01 D-0830-2020